Construction is complete at A/D/O, a new 23,000 square-foot creative space, which opens to the public in Greenpoint, Brooklyn following the holiday season. At the core of A/D/O is its Design Academy, which aims to inspire pioneering work and be a forum for interdisciplinary debate. A/D/O will provide unique opportunities for professional development while inviting the broader public to explore design through a range of installations, exhibitions and events.
The Design Academy at A/D/O will offer an ambitious seasonal program geared towards design professionals, which stimulates relevant dialogue and new work through talks and workshops, special exhibitions and commissions and designer residencies. Its first program, entitled “Utopia vs. Dystopia: Designing Our Imagined Futures,” investigates the role design plays in a world of rapid change. Partnerships with design firms MOS Architects, OLIN, Stephen Burks Man Made and Turner-prize winning collective Assemble, as well as talks from Yves Behar and Alice Rawsthorn among others, are important components of this inaugural season, which will kick off with a three-day festival January 27-29, 2017.
To view the multimedia release go to:
http://www.multivu.com/players/English/7978851-a-d-o-opens-design-academy-greenpoint-brooklyn/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
WDIV's 'Live in the D' take a fall color tour in a hot air balloon with Scott Lorenz of Weswind Balloon Co of Plymouth, Michigan. The flight covered Milford, Brighton and South Lyon Michigan in a glorious flight over the country side. Sights included the GM Proving Grounds, Horses in pastures, the bird sanctuary in Kensington Park, the gun range at Island Lake State Park and the Huron River. To schedule a flight visit: http://www.westwindcos.com/balloon or call 734-667-2098.
PORTER CABLE® announces the launch of its 20V MAX* Lithium Ion Brushless Drill/Driver (PCCK607LB) and 20V MAX* Lithium Ion Brushless Impact Driver (PCCK647LB), which are both part of the new Brushless EDGE™ family of tools. The 20V MAX* Lithium Ion Brushless Drill/Driver and 20V MAX* Lithium Ion Brushless Impact Driver are extensions to the 20V MAX* Get Linked System® tools, a range of professional cordless core tools at a great price. These two tools operate on any PORTER CABLE 20V MAX* Lithium Ion battery. Integrating brushless motor technology for the first time in its system of tools, these two new PORTER CABLE brushless products offer up to 50% more runtime** to minimize downtime on the jobsite.
The 20V MAX* Lithium Ion Brushless Drill/Driver (PCCK607LB) boasts more runtime as well as 20% more power and improved bit retention compared to the prior model (PCC601). Its efficient brushless motor, high-speed transmission, and 1.5Ah battery deliver up to 370 Max Watts Out (MWO) to maximize drilling and fastening speeds. A two-speed gear transmission delivers 0-450 Rotations Per Minute (RPM) in low speed for high-torque applications and 0-1,800 RPM in high speed for maximum fastening speed. Since compact size is an important feature for professionals, the 20V MAX* Lithium Ion Brushless Drill/Driver is just 7.4 inches in length and weighs only 3.3 pounds with its battery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7517856-porter-cable-announces-brushless-edge/
Expanding the functionality of Internet of Things (IoT) networks, Texas Instruments (TI) (NASDAQ: TXN) today announced availability for mass production of the industry’s lowest-power dual-band wireless microcontroller (MCU) supporting Sub-1 GHz and Bluetooth® low energy connectivity on a single chip. As part of TI’s pin-to-pin and software compatible SimpleLink™ ultra-low power platform, the new SimpleLink dual-band CC1350 wireless MCU enables developers to move from a three-chip solution to a tiny single chip, while reducing design complexity, saving power, cost and board space. The CC1350 wireless MCU offers a range of up to 20 km on a coin cell battery for building and factory automation, alarm and security, smart grid, asset tracking and wireless sensor network applications. For more information, visit www.ti.com/cc1350-pr.
To view the multimedia release go to:
http://www.multivu.com/players/English/7746254-texas-instruments-simplelink-dual-band-cc1350/
Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Tektronix, a leading worldwide provider of measurement solutions, today introduced the TBS2000, a next generation basic oscilloscope featuring the longest record length and largest display in its class for faster signal evaluation and troubleshooting. This latest addition to the Tektronix portfolio puts expanded capabilities, including the ability to use a wide range of Tektronix probes, into the hands of budget-constrained design engineers and educators.
“Building on the success of the TDS2000 Series, the most widely used oscilloscope in the world, the new TBS2000 gives our customers a level of design insight previously not available in this class of instrument,” said Jeff Yost, director, Basic Oscilloscopes, Tektronix. “The new instrument also sets a new standard for usability with features like a large display for easy signal visualization and a comprehensive set of automatic waveform measurements that are coupled with graphical explanations to help engineers better understand their measurements.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7724651-tektronix-tbs2000-series-oscilloscope/
Scotch is a drink embraced and enjoyed wherever, whenever. It is the world’s favorite whisky, and we bet you didn’t know that it’s the only drink that offers a diverse range of tastes, textures and flavours. Whether neat, on the rocks or in a cocktail, there is no right or wrong way to drink Scotch whisky. As long as you enjoy it (responsibly, of course!) that’s all that matters. It is also the ideal gift for men. If you are confused what to gift your man, don’t hesitate anymore and get him a bottle of Scotch Whisky! A gift which he will not only appreciate but also cherish.
Scotch whisky is found in the hands of arbiters of style around the world, and India is no different. On the occasion of World Whisky Day on 21st May, USL-Diageo, India’s leading premium drinks Company introduced Bangalore to its biggest global campaign ‘#LoveScotch’. Indulging the audience with their favorite Scotch whisky stories were Canadian Super Model and Global #LoveScotch Ambassador Coco Rocha, actors Randeep Hooda, Mandira Bedi, Dino Morea, alongside Businessman Rajiv Mehta and Whisky Connoisseur Magandeep Singh.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7891051-stars-with-their-favorite-scotch-whisky/
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
Ringing out, as it has for centuries, the mission bell beckons across the hillsides calling out to the devoted. Here, where lush hillsides meet the Pacific Ocean, we pursue a singular canon—to make great wine. Canon 13 Pinot Noir and Chardonnay from the Santa Lucia Highlands, our answer to the mission bell, launch nationwide in July to on-premise retailers.
“The Santa Lucia Highlands are as unique as the people who settled them,” says Canon 13 winemaker Tom Klassen. “Sitting high on a bench overlooking a fertile valley, the vines grow deep in the alluvial soils that cling to the hillsides. Our fruit is protected by the maritime breezes that bring with them a gentle fog, ensuring the grapes ripen evenly and provide our wines with supple texture and fragrant aromatics found nowhere else.”
Canon 13 is inspired by our geographic birthplace at the Soledad Mission, the 13th mission located along the El Camino Real, the historic 600-mile stretch of road connecting dozens of missions and pueblos beginning in the late 1700s. The steep Santa Lucia Highlands are located along California’s central coast, near the cool waters of Monterey Bay on the flanks of the Santa Lucia Range. The region is graced by warm days, cool nights, rich soil and an evening fog that nurtures the delicate Chardonnay and Pinot Noir grapes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7409459-canon-13-wines-launch/
Tesla has unveiled its highly anticipated Model 3 electric car.
Customers have been looking forward to a lower-cost way to buy one of the California-based company's products, while investors hope it will swing the company from loss to profit.
But other more established automakers are launching electric vehicles of their own targeted at the same market.
Subscribe to BBC News HERE http://bit.ly/1rbfUog
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews
First experience in the prototype Tesla Model 3 $35,000 electric car. This is the dual-motor version - the entry level car will be single-motor, RWD.
More details at http://www.slashgear.com/tags/tesla
